Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 5
Submit an article Journal homepage
719
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Medical resource use and costs associated with chylomicronemia

Daniel GaudetEcogene-21 Clinical Research Center and Department of Medicine, Université de Montréal MontrealCanadaCorrespondence[email protected]
,
James SignorovitchAnalysis Group Inc Boston, MAUSA
,
Elyse SwallowAnalysis Group Inc Boston, MAUSA
,
Liangyi FanAnalysis Group Inc Boston, MAUSA
,
Karine TremblayEcogene-21 Clinical Research Center and Department of Medicine, Université de Montréal MontrealCanada
,
Diane BrissonEcogene-21 Clinical Research Center and Department of Medicine, Université de Montréal MontrealCanada
,
Charles MeyersNovartis Pharma AG BaselSwitzerland
&
Jean-Bernard GruenbergerNovartis Pharma AG BaselSwitzerland
 show all
Pages 657-666 | Accepted 19 Feb 2013, Published online: 11 Mar 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Isabel Shamsudeen & Robert A. Hegele. (2022) Safety and efficacy of therapies for chylomicronemia. Expert Review of Clinical Pharmacology 15:4, pages 395-405.
Read now
Julieta Lazarte & Robert A. Hegele. (2021) Volanesorsen for treatment of familial chylomicronemia syndrome. Expert Review of Cardiovascular Therapy 19:8, pages 685-693.
Read now
Marcello Arca, Andrew Hsieh, Handrean Soran, Paul Rosenblit, Louis O’Dea & Michael Stevenson. (2018) The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study. Expert Review of Cardiovascular Therapy 16:7, pages 537-546.
Read now
Lane B. Benes, Eric J. Brandt & Michael H. Davidson. (2018) Advances in diagnosis and potential therapeutic options for familial chylomicronemia syndrome. Expert Opinion on Orphan Drugs 6:2, pages 141-149.
Read now

Articles from other publishers (9)

Bilal Bashir, Jan H. Ho, Paul Downie, Paul Hamilton, Gordon Ferns, Dev Datta, Jaimini Cegla, Anthony S. Wierzbicki, Charlotte Dawson, Fiona Jenkinson, Hannah Delaney, Michael Mansfield, Yee Teoh, Zosia Miedzybrodzka, Haya Haso, Paul N. Durrington & Handrean Soran. (2023) Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options. Metabolites 13:5, pages 621.
Crossref
Amitabh V. Nimonkar, Stephen Weldon, Kevin Godbout, Darrell Panza, Susan Hanrahan, Rose Cubbon, Fangmin Xu, John W. Trauger, Jiaping Gao & Andrei Voznesensky. (2020) A lipoprotein lipase–GPI-anchored high-density lipoprotein–binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome. Journal of Biological Chemistry 295:10, pages 2900-2912.
Crossref
Josep Julve, Jesús M. Martín-Campos, Joan Carles Escolà-Gil & Francisco Blanco-Vaca. (2016) Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics. Clinica Chimica Acta 455, pages 134-148.
Crossref
Charles Daniel Meyers, Karine Tremblay, Ahmed Amer, Jin Chen, Liewen Jiang & Daniel Gaudet. (2015) Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome. Lipids in Health and Disease 14:1.
Crossref
Amanda J. Brahm & Robert A. Hegele. (2015) Chylomicronaemia—current diagnosis and future therapies. Nature Reviews Endocrinology 11:6, pages 352-362.
Crossref
Peter P. Toth, Michael Grabner, Nadia Ramey & Keiko Higuchi. (2014) Clinical and economic outcomes in a real-world population of patients with elevated triglyceride levels. Atherosclerosis 237:2, pages 790-797.
Crossref
M John Chapman, Henry N Ginsberg & Robert A Hegele. (2014) Treatment of severe hypertriglyceridaemia – Authors' reply. The Lancet Diabetes & Endocrinology 2:11, pages 860-861.
Crossref
Karine Tremblay, Camélia Dubois-Bouchard, Diane Brisson & Daniel Gaudet. (2014) Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency. Frontiers in Genetics 5.
Crossref
Gerald F. Watts, Esther M. M. Ooi & Dick C. Chan. (2013) Demystifying the management of hypertriglyceridaemia. Nature Reviews Cardiology 10:11, pages 648-661.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.